CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Efficacy, safety, and cancer-related symptoms in patients with hepatocellular carcinoma with alpha-fetoprotein ≥400 ng/ml: A pooled analysis from REACH and REACH-2 studies
DOI 10.1055/s-0039-1691925
Bibliografische Angaben
Nachweis in CareLit
Autor:innenI Borbath, M Kudo, RS Finn, PR Galle, JM Llovet, J Blanc, T Okusaka, I Chau, D Cella, M Peck-Radosavljevic, A Girvan, J Gable, L Bowman, P Abada, Y Hsu, AX Zhu
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2019
Jahrgang / SeitenJg. 57
Kernaussage aus der Literatur
Abstract-Vorschau
Efficacy, safety, and cancer-related symptoms in patients with hepatocellular carcinoma with alpha-fetoprotein ≥400 ng/ml: A pooled analysis from REACH and REACH-2 studies
Zitieren
Zitierempfehlung
I Borbath, M Kudo, RS Finn, PR Galle, JM Llovet, J Blanc, T Okusaka, I Chau, D Cella, M Peck-Radosavljevic, A Girvan, J Gable, L Bowman, P Abada, Y Hsu, AX Zhu (2019) Efficacy, safety, and cancer-related symptoms in patients with hepatocellular carcinoma with alpha-fetoprotein ≥400 ng/ml: A pooled analysis from REACH and REACH-2 studies. Zeitschrift für Gastroenterologie, 57 (05). https://doi.org/10.1055/s-0039-1691925
Mit CareLit weiterarbeiten